EVGN
Income statement / Annual
Last year (2025), Evogene Ltd's total revenue was $3.85 M,
a decrease of 30.91% from the previous year.
In 2025, Evogene Ltd's net income was -$8.49 M.
See Evogene Ltd,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$3.85 M |
$5.58 M |
$2.98 M |
$1.68 M |
$930.00 K |
$1.04 M |
$753.00 K |
$1.75 M |
$3.38 M |
$6.54 M |
| Cost of Revenue |
$4.09 M
|
$2.38 M
|
$1.49 M
|
$909.00 K
|
$767.00 K
|
$574.00 K
|
$334.00 K
|
$1.45 M
|
$2.85 M
|
$5.64 M
|
| Gross Profit |
-$241.00 K
|
$3.20 M
|
$1.49 M
|
$766.00 K
|
$163.00 K
|
$466.00 K
|
$419.00 K
|
$295.00 K
|
$536.00 K
|
$901.00 K
|
| Gross Profit Ratio |
-0.06
|
0.57
|
0.5
|
0.46
|
0.18
|
0.45
|
0.56
|
0.17
|
0.16
|
0.14
|
| Research and Development Expenses |
$7.99 M
|
$12.51 M
|
$16.20 M
|
$20.79 M
|
$21.13 M
|
$17.29 M
|
$15.79 M
|
$14.69 M
|
$16.99 M
|
$16.41 M
|
| General & Administrative Expenses |
$5.58 M
|
$8.75 M
|
$7.37 M
|
$10.28 M
|
$9.34 M
|
$7.47 M
|
$5.79 M
|
$5.60 M
|
$5.50 M
|
$5.59 M
|
| Selling & Marketing Expenses |
$185.00 K
|
$224.00 K
|
$162.00 K
|
$132.00 K
|
$653.00 K
|
$520.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$5.76 M
|
$8.98 M
|
$7.53 M
|
$10.42 M
|
$9.99 M
|
$7.99 M
|
$5.79 M
|
$5.60 M
|
$5.50 M
|
$5.59 M
|
| Other Expenses |
$37.00 K
|
$514.00 K
|
$0.00
|
-$3.50 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$13.79 M
|
$22.00 M
|
$23.72 M
|
$27.71 M
|
$31.12 M
|
$25.28 M
|
$21.59 M
|
$20.28 M
|
$22.48 M
|
$21.99 M
|
| Cost And Expenses |
$17.89 M
|
$24.38 M
|
$25.21 M
|
$28.62 M
|
$31.88 M
|
$25.85 M
|
$21.92 M
|
$21.74 M
|
$25.33 M
|
$27.63 M
|
| Interest Income |
$2.47 M
|
$957.00 K
|
$1.25 M
|
$182.00 K
|
$291.00 K
|
$230.00 K
|
$759.00 K
|
$1.41 M
|
$2.13 M
|
$2.40 M
|
| Interest Expense |
$1.89 M
|
$124.00 K
|
$171.00 K
|
$241.00 K
|
$403.00 K
|
$269.00 K
|
$354.00 K
|
$141.00 K
|
$129.00 K
|
$155.00 K
|
| Depreciation & Amortization |
$1.14 M
|
$1.38 M
|
$1.30 M
|
$2.58 M
|
$2.23 M
|
$2.73 M
|
$2.77 M
|
$2.02 M
|
$2.15 M
|
$2.28 M
|
| EBITDA |
-$12.20 M |
-$13.36 M |
-$20.53 M |
-$27.01 M |
-$27.88 M |
-$23.21 M |
-$16.02 M |
-$18.76 M |
-$18.68 M |
-$18.81 M |
| EBITDA Ratio |
-3.17
|
-2.4
|
-6.89
|
-16.12
|
-29.98
|
-22.32
|
-21.27
|
-10.74
|
-5.53
|
-2.88
|
| Operating Income Ratio |
-3.64
|
-3.37
|
-7.46
|
-16.08
|
-33.28
|
-23.86
|
-28.11
|
-11.44
|
-6.49
|
-3.22
|
| Total Other Income/Expenses Net |
$536.00 K
|
$4.00 M
|
$285.00 K
|
-$2.81 M
|
$521.00 K
|
-$1.36 M
|
$2.08 M
|
-$793.00 K
|
$1.12 M
|
$1.53 M
|
| Income Before Tax |
-$13.50 M
|
-$14.81 M
|
-$21.95 M
|
-$29.75 M
|
-$30.43 M
|
-$26.17 M
|
-$19.09 M
|
-$20.78 M
|
-$20.83 M
|
-$19.56 M
|
| Income Before Tax Ratio |
-3.5
|
-2.66
|
-7.36
|
-17.76
|
-32.72
|
-25.17
|
-25.35
|
-11.9
|
-6.16
|
-2.99
|
| Income Tax Expense |
$1.00 K
|
$9.00 K
|
$19.00 K
|
$90.00 K
|
$13.00 K
|
$32.00 K
|
$24.00 K
|
$30.00 K
|
$11.00 K
|
$36.00 K
|
| Net Income |
-$8.49 M
|
-$16.49 M
|
-$23.88 M
|
-$26.64 M
|
-$27.79 M
|
-$23.37 M
|
-$18.11 M
|
-$20.76 M
|
-$20.84 M
|
-$19.59 M
|
| Net Income Ratio |
-2.2
|
-2.96
|
-8.01
|
-15.9
|
-29.88
|
-22.48
|
-24.05
|
-11.88
|
-6.16
|
-3
|
| EPS |
-1.08 |
-2.89 |
-5.23 |
-6.46 |
-0.68 |
-0.64 |
-0.7 |
-0.81 |
-0.81 |
-0.77 |
| EPS Diluted |
-1.08 |
-2.89 |
-5.23 |
-6.46 |
-0.68 |
-0.64 |
-0.7 |
-0.81 |
-0.81 |
-0.77 |
| Weighted Average Shares Out |
$7.87 M
|
$5.70 M
|
$4.57 M
|
$4.12 M
|
$41.01 M
|
$36.55 M
|
$25.75 M
|
$25.75 M
|
$25.73 M
|
$25.44 M
|
| Weighted Average Shares Out Diluted |
$7.87 M
|
$5.70 M
|
$4.57 M
|
$4.12 M
|
$41.01 M
|
$36.55 M
|
$25.75 M
|
$25.75 M
|
$25.73 M
|
$25.44 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
